<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 12 Mar 2021 21:00:00 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>从胎儿时期治疗脊柱裂患者！全球首次干细胞“贴片”疗法纳入临床试验丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/CQSoeshfGzmLwQQqWrc79g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIukUlhy1w2icchZa8b89Pibug7NVzRC5PIy9RYs85o0unwKu86oaEfwoyfGia07oqHweycF6Sw6aYnvQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>干细胞“贴片”疗法，在胎儿时期就开始了]]></content:encoded><pubDate>Fri, 12 Mar 2021 07:47:55 +0800</pubDate></item><item><title>蓝鸟生物股价飙升14%以上，最新调查结果显示慢病毒载体不会诱发癌症丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/nnbPtVdxdE-SrexPjzGQ_w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jn7Grkxp8c9EzeWWnUibJ4XY6yuE7mSO3Z01eooAicz3sLiaf2gVfaTibjBlAGsHyKcccSdU7JibeZCDjG3YAmEzJnA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>首次报告基因治疗临床研究中白血病（ AML）的病因]]></content:encoded><pubDate>Fri, 12 Mar 2021 07:47:55 +0800</pubDate></item><item><title>5.25亿美元收购案，武田重金布局T细胞接合剂丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/vhybYPMHOi1NDeyyXIxbMQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIukUlhy1w2icchZa8b89PibugYOPLvhMIdGJjzRUqe70ykwnsibDjssUeIEDr1DzHAibsCdSQzLbtvXCA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>T细胞接合剂前景广泛]]></content:encoded><pubDate>Fri, 12 Mar 2021 07:47:55 +0800</pubDate></item><item><title>药融资丨8000万美元！Grifols收购多克隆抗体公司</title><link>https://mp.weixin.qq.com/s/erEZhA-i2n6LZfSjOSDjFA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIukUlhy1w2icchZa8b89PibugN8ZtrUia2OFmJOFyqricF1ib84GJBBNyguNNniblMNyEJ3K4sib1uGuyqcg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>半年多笔大额收购计划]]></content:encoded><pubDate>Fri, 12 Mar 2021 07:47:55 +0800</pubDate></item><item><title>mRNA新冠疫苗在中国香港开打，约百名优先组别人士接种丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/7DWDHIWEdBLwpnbqFCANcQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItFcdibBzFqK7etfw9qDAz4ibEvs31x7qkbibGdYiaic2Esn2BAeic0De6WylFVPMeGs2THVz4djMak8XTQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第二批75.8万剂运抵，新增12间疫苗接种中心供应]]></content:encoded><pubDate>Wed, 10 Mar 2021 23:44:36 +0800</pubDate></item><item><title>强强联合！特斯拉与CureVac合作开发mRNA药物打印机丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/PzgvMkRGwqsR6LU8TKHvuQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItFcdibBzFqK7etfw9qDAz4ibxGwZemr0CrL7tWS6sZGJAicInx5pGvvFXjIpTiaaTiasibemxbXJtdXV7w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>便携式、自动化mRNA生产“微工厂”]]></content:encoded><pubDate>Wed, 10 Mar 2021 23:44:36 +0800</pubDate></item><item><title>基因治疗时代来临！三款AAV基因疗法获美国FDA快速通道称号丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Tf6iI3WW4HzfztH1lZd7tg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItFcdibBzFqK7etfw9qDAz4ibcKswkhib0ib0fjKBkERMGbED13ibBqibVWzKfhSYcGGpPicV9cvvXhvA1vQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Passage Bio公司创建的三款基因疗法PBGM01、PBFT02和PBKR03同日获得美国FDA快速通道称号。]]></content:encoded><pubDate>Wed, 10 Mar 2021 23:44:36 +0800</pubDate></item><item><title>3D打印技术，未来还会有什么产品造福人类？丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/3zOSK1rHviV44T6sBvvqDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItFcdibBzFqK7etfw9qDAz4ib5hR76GlE59BCKkwLuUZBAH0rxVHCr4J8Gjht3webTD07Ta5TicMOYlw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>造福人类。]]></content:encoded><pubDate>Wed, 10 Mar 2021 23:44:36 +0800</pubDate></item><item><title>第一梯队“进击”医院的关键时期，PD-1商业化路向何方？丨峰客浅析</title><link>https://mp.weixin.qq.com/s/ZUwITsUY01FDxBAq8vcWlg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItFcdibBzFqK7etfw9qDAz4ib2xknMI40VtsYvzo5DBibnBQkX8PTTwbNUgRgkzj0XBLQCvZWUZvv9Pg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>— 本栏目由赛默飞世尔科技独家冠名赞助 — “ 导读：PD-1市场竞争日趋激烈，全球在两三年内，预计将迎来超]]></content:encoded><pubDate>Wed, 10 Mar 2021 23:44:36 +0800</pubDate></item><item><title>珠璧联辉丨和元生物与康晟生物就Wayne293™宿主细胞平台及高产毒衍生细胞株共同开发达成战略合作</title><link>https://mp.weixin.qq.com/s/WXjGjpN9dj_dLT75hzPLtg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/gxB1svTgKicY39jVKcZmOysmNCq1xKcC7XlqXZicufFJCoGLVh0xU7eDTiadWdNv4niaqfT2BDnmGESbkye2l7wMyQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>推动中国地区细胞治疗与基因治疗行业快速发展]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>新型免疫治疗系列直播预告丨Cytiva携手知名CDMO打造生物制药工艺系列线上课程</title><link>https://mp.weixin.qq.com/s/E634aJeqA-bNXvR9PRhlLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMehJT1BPNjV9XbCuK9RxbvhIoxjZyWEI0hXeDWibWfOnwVbHd0ytesfw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月11起每周四晚19:30，直播间不见不散！]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>FDA曾拒绝的A型血友病基因疗法，如今再获再生医学先进疗法指定丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/ToheQiXxaGVeddwLed6Xng</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMLgQvcYgp3XTWIfn57Rc0UY4BBoySibFx0unGMjlNwiaN5AEA9WIaeXDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>A型血友病基因疗法研发赛道，你追我赶。]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>EpCAM靶向ADC向欧洲递交上市申请，预计2022年初获批丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/OKAAuu2lW4cBPfTBJ64qXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMQiaOJptURntWcxjiaegoicKbjqswLphKCA9a7w8rjxZYhlAmDHaLV0ibRA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ADC未来可期]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>药融资丨澳斯康生物制药完成超4亿元人民币C轮融资</title><link>https://mp.weixin.qq.com/s/6XzNNoa34AkTZAUJFF_HYw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMgakGmCkS9JVkX3ZSG967AIiao8ibT74aXrI6GtsFCiat47djcbFGUs0ZA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本轮融资将有助于打造全球最大的培养基生产基地和国际领先的CDMO平台]]></content:encoded><pubDate>Wed, 10 Mar 2021 08:00:46 +0800</pubDate></item><item><title>2020年细胞疗法监管政策回顾，细胞疗法走向正轨丨医麦新观察</title><link>https://mp.weixin.qq.com/s/qS6TJMeCg4AbEwUxR1Hkcg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYht4lmLPU6O5fOPU8dPpNoGwPiafSub60Oc75plYXc459sp7GUvdwHCYsw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>火热的细胞疗法]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>新型CAR-T技术获得欧洲专利，针对卵巢癌的临床研究即将启动丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/FtRIWhT5mmQZKCm4c6G9eQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItyR1Mco98RdibvF34WOoVHMmWvhI0bCcFojS5wqibsibZkRyKPbYiatwib9uNfos5Yys9vgwWS21RfOYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>向实体瘤发起挑战]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>装甲溶瘤腺病毒已经完成首例患者给药，表达OX40L配体增强肿瘤杀伤效果丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Bzw0h4bW8dgsPzQV64FDGA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtzFvYJGBk8QjoGxoLkUnktcN897L6Pa5Q1BWtGERlFqt6xDKSVEYYow/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>溶瘤病毒是联合治疗策略中的理想对象，成为肿瘤免疫研究中的热门方向]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>重磅！美国FDA加速批准Yescarta第二个适应症丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/6Y_jbcgYBt2boAH03-j-jg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtmI25RWpQBIUaPpWqDILh3MjhgAXIJgQ01SLsic4ve4NjdMQJEENZHjA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Yescarta全球布局]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>药融资丨拜耳支持的iPSC公司完成1.6亿美元C轮融资，加快iPSC衍生疗法开发</title><link>https://mp.weixin.qq.com/s/unmDHuDpa4fkaT3BaS1pFQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI6KQUlD2q6cGYrEiba5b7119jiaiaDYBwCDhep2IShKbkd2WfeGQrDGBKM1pd2Xn9kRSz6RiakLXWOFUw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>iPSC巨大潜力]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:05:24 +0800</pubDate></item><item><title>优卡迪首款创新型CAR-T药物临床试验启动会顺利召开丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/bCNdmNGjSudpt1O24zxdRw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuUpTnXjPnxLO3t1rkicOYhtzHYKgrDpVHPQWBzHHOLrnFZhiagLEFSMCdBbbxKcnkSWfYkHx5GVlHw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>以CD19为靶点，同时携带IL-6沉默元件的CAR-T]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:57:49 +0800</pubDate></item></channel></rss>